Sucampo Pharmaceuticals, Inc.
Mallinckrodt is a company with a heritage of over 150 years, committed to quality, integrity, and service. It is dedicated to the development and commercialization of pharmaceutical products, including treatments for rare diseases, and emphasizes sustainability, compliance, and innovation. The company has integrated Sucampo Pharmaceuticals and continues to focus on advancing its product pipeline and supporting patient needs.
Industries
Nr. of Employees
medium (51-250)
Sucampo Pharmaceuticals, Inc.
Products
Investigational therapy for Niemann-Pick Disease Type C
Development-stage therapeutic candidate intended to treat Niemann-Pick Disease Type C (investigational program).
Investigational therapy candidate for familial adenomatous polyposis
Development-stage combination therapy candidate intended to address familial adenomatous polyposis (investigational program).
Regenerative skin graft products in development
Development-stage regenerative skin tissue constructs and genetically modified skin substitutes intended for clinical use in skin repair and replacement.
Commercialized gastrointestinal therapeutics (marketed products)
Continued commercialization and market support for approved gastrointestinal therapeutics in the U.S. and Japan.
Investigational therapy for Niemann-Pick Disease Type C
Development-stage therapeutic candidate intended to treat Niemann-Pick Disease Type C (investigational program).
Investigational therapy candidate for familial adenomatous polyposis
Development-stage combination therapy candidate intended to address familial adenomatous polyposis (investigational program).
Regenerative skin graft products in development
Development-stage regenerative skin tissue constructs and genetically modified skin substitutes intended for clinical use in skin repair and replacement.
Commercialized gastrointestinal therapeutics (marketed products)
Continued commercialization and market support for approved gastrointestinal therapeutics in the U.S. and Japan.
Services
Supplier onboarding and qualification
Supplier prequalification, orientation, EHS training and contractual onboarding aligned to procurement and PSCI principles.
Strategic sourcing and procurement optimization
Strategic sourcing processes to identify suppliers that meet quality, cost, service and regulatory requirements and support operational excellence.
Supplier onboarding and qualification
Supplier prequalification, orientation, EHS training and contractual onboarding aligned to procurement and PSCI principles.
Strategic sourcing and procurement optimization
Strategic sourcing processes to identify suppliers that meet quality, cost, service and regulatory requirements and support operational excellence.
Expertise Areas
- Drug commercialization and lifecycle management
- Rare disease drug development
- Regenerative medicine and tissue engineering
- Regulatory submissions and compliance (U.S. and Japan)
Key Technologies
- Regenerative medicine and tissue engineering
- Genetically modified human tissue constructs
- Rare disease therapeutic platforms
- Pediatric clinical development methodologies